Clinical Trial

Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.

Study acronym: OASIS²
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, retrospective, multicenter study based on the use of demographic, clinical and biological data from deceased patients admitted between 2018 and 2022 to critical care with a principal or associated diagnosis of joint prosthesis infection. Data from this study will be combined with that from the OASIS study (APHP241174/ ID-RCB: 2024-A01769-38) concerning osteoarticular sepsis on prosthetic material in critical care of living patients. The aim of this study is to improve our knowledge of the profile, care trajectories and outcomes of patients hospitalized in critical care in the context of osteoarticular material sepsis. The results of the study could help identify at-risk populations and improve management strategies for patients with osteoarticular sepsis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-04; most recent amendment 2026-05-29.
Status change: Not Yet Recruiting → Recruiting 2025-09-25
Trial Details
NCT Number NCT07107685
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Osteoarticular Infections, Intensive Care Patients, Prosthetic Joint Infection
Enrollment 150 participants
Start Date 2025-09-24
Primary Completion 2026-09-24 (estimated)
Study Completion 2026-09-24 (estimated)
Updated on ClinicalTrials.gov 2026-06-01